LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.56234
 47.93 27.76 132 4421 0.0299 0.2376
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 47.93 27.76 1084 4421 0.2452 0.6503
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 49.63 27.76 1049 4818 0.2177 0.6294
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 49.63 27.76 1072 4818 0.2225 0.6342
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 49.63 27.76 132 4818 0.0274 0.2332
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 49.63 27.76 1094 4818 0.2271 0.6386
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 51.33 27.76 1060 5117 0.2072 0.6225
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 51.33 27.76 1091 5117 0.2132 0.6287
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 51.33 27.76 126 5117 0.0246 0.2226
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 51.33 27.76 1095 5117 0.2140 0.6295
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 53.04 27.76 1063 5365 0.1981 0.6160
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 53.04 27.76 1105 5365 0.2059 0.6243
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 53.04 27.76 120 5365 0.0224 0.2126
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 53.04 27.76 1103 5365 0.2056 0.6239
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 54.74 27.76 1111 5606 0.1982 0.6190
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 54.74 27.76 1138 5606 0.2030 0.6240
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 54.74 27.76 138 5606 0.0246 0.2330
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 54.74 27.76 1105 5606 0.1971 0.6178
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 56.45 27.76 976 5745 0.1699 0.5884
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 56.45 27.76 1059 5745 0.1843 0.6053
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 56.45 27.76 150 5745 0.0261 0.2452
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 56.45 27.76 1094 5745 0.1904 0.6121
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 58.15 27.76 959 5906 0.1624 0.5810
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 58.15 27.76 1069 5906 0.1810 0.6034
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 58.15 27.76 154 5906 0.0261 0.2480
MN20160318_Q01
L13